Status:
RECRUITING
Biomarkers in the Diagnosis and Prognosis of NAFLD
Lead Sponsor:
University of Trieste
Conditions:
NAFLD
Obesity
Eligibility:
All Genders
18-65 years
Brief Summary
Fibrosis is considered the leading cause of liver diseases and related mortality. Specifically, hepatic fibrosis is regarded as the consequence of reparative mechanisms initiated by hepatocytes in res...
Detailed Description
Project Description: In modern society, with the advent of industrial development, lifestyle has been greatly modified, leading to unhealthy habits such as overeating and fast food consumption (follo...
Eligibility Criteria
Inclusion
- BMI\> 35 Eligible for bariatric surgery according to the current international guidelines (IFSO guidelines)
Exclusion
- Patients affected by active liver viral infection
- Patient alcohol or drug addicted
- Incompetent patients
Key Trial Info
Start Date :
September 22 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 22 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06098417
Start Date
September 22 2015
End Date
September 22 2026
Last Update
October 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Silvia Palmisano
Trieste, Italy, 34100